Skip to content

AMT (3‐(2‐aminopropyl)indole) and 5‐IT (5‐(2‐aminopropyl)indole): an analytical challenge and implications for forensic analysis

Simon Elliott, Simon D. Brandt, Sally Freeman, Roland Archer

Drug Testing and Analysis October 5, 2012 DOI: 10.1002/dta.1420 via OpenAlex

Summary

AI-generated from the abstract

5-(2-Aminopropyl)indole (5-IT) and 3-(2-aminopropyl)indole (α-methyltryptamine, AMT) are isomeric substances that are difficult to differentiate under routine analytical conditions, especially without reference material. Subtle differences in mass spectral and UV conditions can facilitate their differentiation. Analyses included 1H and 13C NMR, GC-EI/CI ion trap MS, and several U/HPLC-DAD and HPLC-MS methods. AMT was detected in a number of fatal intoxications, and there is a potential risk of misidentification when dealing with both substances.

Study at a glance

Characteristics Report Peer reviewed
Keywords Indole test Medicinal chemistry Chromatography
Citations 36
Key finding Subtle differences in mass spectral and UV conditions can help differentiate the isomers 5-IT and AMT, and AMT was detected in fatal intoxications, highlighting a risk of misidentification.

Abstract

5‐(2‐Aminopropyl)indole (5‐IT) and 3‐(2‐aminopropyl)indole (α‐methyltryptamine, AMT) are isomeric substances and their differentiation can be a challenge under routine analytical conditions, especially when reference material is unavailable. 5‐IT represents a very recent addition to the battery of new psychoactive substances that are commercially available from online retailers. This report illustrates how subtle differences observed under mass spectral and UV conditions can help to facilitate the differentiation between the two isomers. Analyses included 1 H and 13 C NMR, GC‐EI/CI ion trap MS, applications of several U/HPLC‐DAD and HPLC‐MS methods. Investigations currently underway also highlight the confirmation that AMT was detected in a number of fatal intoxications. These findings also demonstrate that there is a potential risk of misidentification when dealing with both substances. Copyright © 2012 John Wiley & Sons, Ltd.

Comments

No comments yet.

Log in to comment